Why it was recalled
Labelling: Incorrect Exp. Date
Product description
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
Lot numbers, UPCs & expiration codes
Lot # 100023805, Exp. Date 05/2023
Where it was sold
Distributed Nationwide in the USA
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0232-2022
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Oct 27, 2021
- FDA report date
- Nov 24, 2021
- Quantity
- 32316 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Teva Pharmaceuticals USA
Original FDA data
Every field from FDA enforcement report D-0232-2022, exactly as published.
Show all FDA fields
- City
- Parsippany
- State
- NJ
- Status
- Terminated
- Country
- United States
- Event ID
- 88936
- Address
- 400 Interpace Pkwy
- Code information
- Lot # 100023805, Exp. Date 05/2023
- Postal code
- 07054-1120
- Report date
- Nov 24, 2021
- Product type
- Drugs
- Recall number
- D-0232-2022
- Classification
- Class II
- Recalling firm
- Teva Pharmaceuticals USA
- Product quantity
- 32316 bottles
- Termination date
- Dec 21, 2022
- Reason for recall
- Labelling: Incorrect Exp. Date
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
- Distribution pattern
- Distributed Nationwide in the USA
- Recall initiation date
- Oct 27, 2021
- Initial firm notification
- Letter
- Center classification date
- Nov 15, 2021